384 related articles for article (PubMed ID: 17047379)
1. Pathology of acromegaly.
Horvath E; Kovacs K
Neuroendocrinology; 2006; 83(3-4):161-5. PubMed ID: 17047379
[TBL] [Abstract][Full Text] [Related]
2. Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.
Syro LV; Rotondo F; Serna CA; Ortiz LD; Kovacs K
Pituitary; 2017 Feb; 20(1):84-92. PubMed ID: 27586499
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.
Kurtkaya-Yapicier O; Scheithauer BW; Carney JA; Kovacs K; Horvath E; Stratakis CA; Vidal S; Vella A; Young WF; Atkinson JL; Lloyd RV; Kontogeorgos G
Ultrastruct Pathol; 2002; 26(6):345-53. PubMed ID: 12537759
[TBL] [Abstract][Full Text] [Related]
4. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
[TBL] [Abstract][Full Text] [Related]
5. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
6. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
8. Pathology of growth hormone-producing tumors of the human pituitary.
Kovacs K; Horvath E
Semin Diagn Pathol; 1986 Feb; 3(1):18-33. PubMed ID: 3303228
[TBL] [Abstract][Full Text] [Related]
9. Therapy for the syndromes of GH excess.
Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
[TBL] [Abstract][Full Text] [Related]
10. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-secreting adenomas: pathology and cell biology.
Lopes MB
Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
[TBL] [Abstract][Full Text] [Related]
12. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of acromegaly.
Melmed S; Braunstein GD; Horvath E; Ezrin C; Kovacs K
Endocr Rev; 1983; 4(3):271-90. PubMed ID: 6354702
[TBL] [Abstract][Full Text] [Related]
14. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
[TBL] [Abstract][Full Text] [Related]
15. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755
[TBL] [Abstract][Full Text] [Related]
18. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone.
Sen O; Ertorer ME; Aydin MV; Erdogan B; Altinors N; Zorludemir S; Guvener N
J Clin Neurosci; 2005 Apr; 12(3):318-20. PubMed ID: 15851094
[TBL] [Abstract][Full Text] [Related]
19. A functional thyrotropin- and growth hormone-secreting pituitary adenoma with a ultrastructurally monomorphic feature: a case study.
Ozawa Y; Kameya T; Kasuga A; Naritaka H; Kanda N; Maruyama H; Saruta T
Endocr J; 1998 Apr; 45(2):211-9. PubMed ID: 9700474
[TBL] [Abstract][Full Text] [Related]
20. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.
Varlamov EV; Wood MD; Netto JP; Thiessen J; Kim J; Lim DST; Yedinak CG; Banskota S; Cetas JS; Fleseriu M
Pituitary; 2020 Dec; 23(6):672-680. PubMed ID: 32870441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
